Influence of Age and Neurotoxic HAART Use on Frequency of HIV Sensory Neuropathy

Simple item page
dc.contributor.authorOshinaike, O.
dc.contributor.authorAknbami, A.
dc.contributor.authorOjo, O.
dc.contributor.authorOgbera, A.
dc.contributor.authorOkubadejo, N.U.
dc.contributor.authorOjini, F.
dc.contributor.authorDanesi, M.
dc.date.accessioned2019-11-02T14:49:56Z
dc.date.available2019-11-02T14:49:56Z
dc.date.issued2012-04-17
dc.description.abstractBACKGROUND: Sensory neuropathy (SN) is one of the most common AIDS-associated neurologic disorders especially in the era of highly active antiretroviral therapy (HAART). The aim of this study was to determine the prevalence of SN among highly-active-antiretroviral-therapy- (HAART-) experienced and HAART-naïve HIV-positive individuals and to investigate the relationship to demographic, clinical, and laboratory factors. METHODS: 323 patients with HIV infection (142 on HAART and 181 HAART naïve) were enrolled in a cross-sectional neuropathy screening program. Data was collected using structured questionnaires which contained the brief peripheral neuropathy screening tool of AIDS Clinical Trial Group protocol. Neuropathy was defined by the presence of at least 1 clinical sign in a distal, symmetrical pattern. Patients were classified as symptomatic if they described aching, stabbing, or burning pain, paresthesia, or numbness in a similar distribution. Demographic, clinical, and laboratory details were documented as risk factors. RESULT: The prevalence of sensory neuropathy was 39.0% (126/323), (of which 29/126 (23%)) were symptomatic. Amongst those on HAART, 60/142 (42.3%) had SN compared to 66/181 (36.5%) HAART-naïve individuals (P = 0.29). On multivariate analyses, the independent associations with SN were increasing age (P = 0.03) and current exposure to stavudine (P = 0.00). Gender (P = 0.99) height (P = 0.07) use of HAART (P = 0.50), duration of HAART treatment (P = 0.10), and lower CD4 count (P = 0.12) were not associated with an increased SN risk. CONCLUSION: HIV SN remains common despite improved immunologic function associated with HAART and decreased neurotoxic HAART use. In this cross-sectional analysis, age and stavudine-based therapies were the independent risk factors.en_US
dc.identifier.citationOshinaike O, Akinbami A, Ojo O, Ogbera A, Okubadejo N, Ojini F, Danesi M. Influence of Age and Neurotoxic HAART Use on Frequency of HIV Sensory Neuropathy. AIDS Res Treat. 2012;2012:961510.en_US
dc.identifier.otherdoi: 10.1155/2012/961510.
dc.identifier.urihttps://ir.unilag.edu.ng/handle/123456789/6691
dc.language.isoenen_US
dc.publisherHindawien_US
dc.subjectHIV/AIDSen_US
dc.subjectSensory neuropathyen_US
dc.subjectHAARTen_US
dc.subjectNeurotoxicityen_US
dc.subjectTreatmenten_US
dc.subjectAgeen_US
dc.titleInfluence of Age and Neurotoxic HAART Use on Frequency of HIV Sensory Neuropathyen_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Oshinaike O et al. Sensory neuropathy and age and neurotoxic HAART.pdf
Size:
1.15 MB
Format:
Adobe Portable Document Format
Description:
Main article
Download
License bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Medicine- Scholarly Publications